Stay updated on Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new page revision v3.5.3 has been added to the history, replacing the previous v3.5.2. This indicates a minor page-level update to the record metadata.
    Difference
    0.1%
    Check dated 2026-04-30T18:42:30.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added. Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:05:12.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T17:56:33.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision version updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T14:28:59.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The history adds a new revision entry (v3.4.2) and removes the previous notices (v3.4.1). There are no changes to the study details or results.
    Difference
    1.0%
    Check dated 2026-02-11T01:58:03.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and operating status was added to the page. The record version was updated from v3.4.0 to v3.4.1.
    Difference
    1.0%
    Check dated 2026-02-03T23:24:10.000Z thumbnail image

Stay in the know with updates to Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.